Search
Immunovant Inc
IMVTAdd to Watchlist
36.950USD
-0.700-1.86%
Close 09-18 16:00（ET）
7.63BMarket Cap
LossP/E TTM
Immunovant Inc (IMVT) Stock Price Target & Forecast
Analyst Rating
Based on 17 analysts giving stock ratings to Immunovant Inc in the past month.
Buy
7 Strong Buy
6 Buy
4 Hold
0 Sell
0 Strong Sell
Target Price
48.800USD+33.15%
IMVT Analyst Recommendation Trends
In the current month, IMVT has received 6 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. IMVT average Analyst price target in the last month is 48.800.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
7
7
7
7
7
7
7
7
6
6
6
6
6
6
6
6
4
4
5
5
5
5
4
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17
17
18
18
18
18
17
17
Financial Forecasting
Based on analysts' estimates, IMVT EPS is projected to reach -0.732 in FY2027Q2, following reported EPS of -0.745 in FY2027Q1. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q3
FY2026Q4
FY2027Q1
FY2027Q2
FY2027Q3
Forecast
-0.71
-0.60
-0.62
-0.73
-0.73
Actual
-0.61
-0.73
-0.75
--
--
Surprise
+14.66%
-20.95%
-21.12%
--
--
FAQs
What is Immunovant Inc's price target?
Analysts forecast that Immunovant Inc's price target is USD 44.00, with the highest forecast at USD 57.00 and the lowest forecast at USD 16.00.
How have Immunovant IncIMVT's recent earnings per share performed?
The market expectation was USD -0.75, while Immunovant IncIMVT's earnings per share (EPS) for the previous quarter was USD -0.73. EPS for the next quarter is expected at USD -0.73.
What is the analyst rating for Immunovant Inc?
Based on the ratings of Immunovant Inc's stock from 17 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.